Multiplex Detection Immunoassay Market: Global Industry Analysis and Forecast 2016 - 2024

  • To Be Published : Dec-2016 |
  • Status : Work in progress |
  • Format :

Multiplex immunoassay is a type of assay used in simultaneous analysis of multiple targets in one sample. The word multiplex refers to the highest number of analytes measurement, which are often used in high- throughput settings. These assay are widely used in the field of clinical & point of care diagnostic; genomics; drug development & quality testing; and various laboratory investigation. Among several laboratory diagnostic application, multiplex immunoassay is perfectly appropriate for immune system disorder testing. Further, it is widely used in functional genomics for the detection of proteins and mRNAs within the biological samples and treatment detection of DNA mutation. Based on the use of multiplex immunoassay, the immune-analysis categorized into two types namely planar immunoassay and bead-based immunoassay. The planar immunoassay, the process conducted on 2D planar substrate grid along with the Fluorescence and chemiluminescence reporter. These reports are commonly used due to their high sensitivity and wide dynamic range. On contrary, the bead-based immunoassay allows the multiplexing of 100 different assays in single sample with the use of reagents such as antibodies, antigens, oligonucleotides, and enzyme substrates.

Multiplex immunoassay market is expected to witness exponential growth attributed to the increasing need for improved disease diagnostic techniques along with the reduced cost and minimized errors. The ability of multiplex assay to generate reportable results from one sample leads to its greater adoption for clinical or point of care diagnostics. Moreover, increasing geriatric population prone to infectious and autoimmune disease and increasing prevalence of chronic diseases would contribute to the market growth. Similarly, due to tremendously developing healthcare infrastructure and increasing government expenditure in clinical diagnostics and drug development, the market is expected to witness significant growth during the forecast period. However, stringent regulatory approvals and inadequate reimbursements policies might restrict the market growth.

Multiplex detection immunoassay market is classified on the basis of techniques, application, end users and geography

Based on techniques, multiplex detection immunoassay market is segmented into the following: 

  • Nucleic acid based technique
  • Protein-based multiplex techniques
  • Other multiplex techniques

Based on application, multiplex detection immunoassay market is segmented into the following:

  • Clinical Diagnostic/Point of Care Diagnostic
    • Infectious Disease Testing
    • Autoimmune Disease Testing
    • Pregnancy & Fertility Testing
    • Drugs-of-abuse Testing
    • Other Tests
  • Drug Development
  • Veterinary Diagnostic

Based on the End User, the multiplex detection immunoassay market is segmented into the following:

  • Clinical Laboratories
  • Pharmaceutical Companies
  • Clinical Research Organization
  • Academic Research Institutes

Global multiplex immunoassay detection market is experiencing significant growth attributed to increased demand for high throughput techniques in various research centers, academic institutes, and biopharmaceutical companies. Increased usage of advance and rapid diagnostic techniques compared to conventional methods and high and quality results may positively impact the market dynamics over a given period of forecast. Moreover recent development of newer technologies in multiplex immunoassay may help grow this market significantly.

Geographically multiplex immunoassay detection market is classified into regions viz. North America, Latin America, Europe, Asia-Pacific, Middle East and Africa. North America and Europe will remain key markets for multiplex detection market due to extensive research and development activities and presence of key players in the market. Asia Pacific is anticipated to register positive growth owing to rising government’s investment in life science sector and expanding biopharmaceutical industry in the region. Similarly, Latin America is expected to witness significant growth owing to the increasing number of patients with life threatening diseases. 

Some of the key players in the next generation centrifuge market are Bio-Rad, Thermo Fisher Scientific Inc., EMD Millipore, Renishaw Inc., Quansys Bioscience, BD biosciences, QIAGEN N.V, F. Hoffmann-La Roche AG, and Danaher Corporation to name a few. Key players are adopting product launch and distribution agreement as few of their developmental strategies in order to maintain the market presence and gain the momentum.

The report covers exhaustive analysis on:

  • Multiplex Immunoassay Detection Market Segments
  • Multiplex Immunoassay Detection Market Dynamics
  • Multiplex Immunoassay Detection Market Size, 2016 - 2024
  • Multiplex Immunoassay Detection Market Size & Forecast 2016 to 2024
  • Multiplex Immunoassay Detection Market Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Multiplex Immunoassay Detection Market Drivers and Restraints 

Regional analysis includes

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa 

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size Recent industry trends
  • Key Competition landscape
  • Strategies of key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance
Back To Top